An observational study in Behavioral Addictions, sponsored by Nantes University Hospital. Recruiting at 1 site in France. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2025-11-24.
Sponsored by Nantes University Hospital · Observational
This research aims to provide a better understanding of the factors associated with the evolution of behavioral addictions, and compliance with care. The investigators thus aim to follow patients with several types of behavioral addictions, based on addictive, sociodemographic, clinical and endophenotypical characteristics, as well as their care adhesion.
158 studies on the registry are indexed under Impulsive Behavior; 31 are open to participants now.
This study's planned enrollment of 2,720 is above the median of 120 across 24 observational studies indexed under Impulsive Behavior.
Browse Impulsive Behavior studies →Nantes University Hospital is the lead sponsor of 839 studies on the registry; 195 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients seeking treatment for a behavioral addiction
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
- All consecutive patients seeking treatment at the University Hospital of Nantes for a behavioral addiction and age over 15 will be allowed to participate to the study.
Exclusion Criteria :
Evolution of behavioral addictions
Understand what determines the evolution of behavioral addictions and compliance with care. Study the outcome of patients with behavioral addictions, both in terms of the evolution of of the addictive pathology and associated clinical and endophenotypic characteristics, as well as adherence to care.
Time frame: 8 years
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.